CD24+ cells are abundant in peritoneal implants compared to primary tumorInhibition of JAK/STAT3 pathway reduces OCSC stemness and improves patient’s survivalCD24+ expression is a predictor of poor outcome in patients with ovarian cancerExpression of CD24+ correlates with cancer stage and presence of peritoneal implants and metastases. This evidence concerns the gene CD24 and cancer.